In the last 12 months, insiders at Generate Biomedicines, Inc. ($GENB) filed 64 transactions with the SEC: 12 open-market purchases totaling $150,300,800 and 0 sales totaling $0. Net insider sentiment: net buying.
Generate Biomedicines, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- AFEYAN NOUBAR (Not found) — 38 transactions totaling $150,000,000
- Nally Michael (Chief Executive Officer) — 5 transactions totaling $240,000
- Silvers Jason (President & CFO) — 5 transactions totaling $32,000
- Mendillo Jane L (Not found) — 2 transactions totaling $24,000
- Grous Beth (Chief People Officer) — 2 transactions totaling $4,800
View all SEC Filings for Generate Biomedicines, Inc. (GENB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Nally Michael | Chief Executive Officer | P | Common Stock | 20000 | $12.00 | 2,889,154.0000 | 0 | 0.70% | 0.00% |
| Feb. 26, 2026 | Vessey Rupert | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | Grous Beth | Chief People Officer | P | Common Stock | 300 | $16.00 | 300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Grous Beth | Chief People Officer | A | Stock Option (Right to Buy) | 114020 | $0.00 | 114,020.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | ARNOLD FRANCES | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Lee Laurie Anne | Chief Medical Officer | A | Stock Option (Right to Buy) | 42230 | $0.00 | 42,230.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Martin Sean | Chief Legal Officer & GC | A | Stock Option (Right to Buy) | 190034 | $0.00 | 190,034.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Simonian Nancy A | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | Silvers Jason | President & CFO | P | Common Stock | 500 | $16.00 | 1,500.0000 | 0 | 50.00% | 0.00% |
| March 2, 2026 | Silvers Jason | President & CFO | P | Common Stock | 500 | $16.00 | 1,500.0000 | 0 | 50.00% | 0.00% |
| March 2, 2026 | Silvers Jason | President & CFO | P | Common Stock | 1000 | $16.00 | 1,500.0000 | 0 | 200.00% | 0.00% |
| Feb. 26, 2026 | Silvers Jason | President & CFO | A | Stock Option (Right to Buy) | 295608 | $0.00 | 295,608.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Silvers Jason | President & CFO | A | Stock Option (Right to Buy) | 274493 | $0.00 | 274,493.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 12723940 | $0.00 | 62,673,117.0000 | 0 | 25.47% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 13702224 | $0.00 | 61,110,617.0000 | 0 | 28.90% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 987491 | $0.00 | 62,673,117.0000 | 0 | 1.60% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 2777752 | $0.00 | 62,673,117.0000 | 0 | 4.64% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 2777752 | $0.00 | 61,110,617.0000 | 0 | 4.76% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | P | Common Stock | 1562500 | $16.00 | 62,673,117.0000 | 0 | 2.56% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | P | Common Stock | 1562500 | $16.00 | 62,673,117.0000 | 0 | 2.56% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | P | Common Stock | 1562500 | $16.00 | 62,673,117.0000 | 0 | 2.56% | 0.00% |
| Feb. 26, 2026 | AFEYAN NOUBAR | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series A Preferred Stock | 18483785 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series A Preferred Stock | 17016215 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series A Preferred Stock | 1500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 843881 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 1265822 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 2953586 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 2109704 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series C Preferred Stock | 2531644 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series C Preferred Stock | 1265822 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series C Preferred Stock | 2109704 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2026 | Grigoryan Gevorg | Chief Technology Officer | A | Stock Option (Right to Buy) | 295608 | $0.00 | 295,608.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Grigoryan Gevorg | Chief Technology Officer | A | Stock Option (Right to Buy) | 196368 | $0.00 | 196,368.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | Nally Michael | Chief Executive Officer | C | Common Stock | 658327 | $0.00 | 2,869,154.0000 | 0 | 29.78% | 0.00% |
| Feb. 26, 2026 | Nally Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 844595 | $0.00 | 844,595.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Nally Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 844595 | $0.00 | 844,595.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | Nally Michael | Chief Executive Officer | C | Series A Preferred Stock | 1000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | Bancel Stephane | Not found | C | Common Stock | 724160 | $0.00 | 1,184,989.0000 | 0 | 157.14% | 0.00% |
| Feb. 26, 2026 | Bancel Stephane | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | Bancel Stephane | Not found | C | Series A Preferred Stock | 1100000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | Mendillo Jane L | Not found | P | Common Stock | 1500 | $16.00 | 1,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Mendillo Jane L | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Fanucci Marsha | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Parker Paul Gray | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 12723940 | $0.00 | 62,673,117.0000 | 0 | 25.47% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 13702224 | $0.00 | 61,110,617.0000 | 0 | 28.90% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 987491 | $0.00 | 62,673,117.0000 | 0 | 1.60% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 2777752 | $0.00 | 62,673,117.0000 | 0 | 4.64% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Common Stock | 2777752 | $0.00 | 61,110,617.0000 | 0 | 4.76% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | P | Common Stock | 1562500 | $16.00 | 62,673,117.0000 | 0 | 2.56% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | P | Common Stock | 1562500 | $16.00 | 62,673,117.0000 | 0 | 2.56% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | P | Common Stock | 1562500 | $16.00 | 62,673,117.0000 | 0 | 2.56% | 0.00% |
| Feb. 26, 2026 | AFEYAN NOUBAR | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series A Preferred Stock | 18483785 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series A Preferred Stock | 17016215 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series A Preferred Stock | 1500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 843881 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 1265822 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 2953586 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series B Preferred Stock | 2109704 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series C Preferred Stock | 2531644 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series C Preferred Stock | 1265822 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 2, 2026 | AFEYAN NOUBAR | Not found | C | Series C Preferred Stock | 2109704 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |